Drug Profile
Research programme: parasitic disease therapeutics and vaccines - Eisai/Oswaldo Cruz Foundation
Alternative Names: E 6446; E6446 analogues - Eisai/Oswaldo Cruz Foundation (Fiocruz); Malaria therapeutics and vaccines - Eisai/Oswaldo Cruz Foundation (Fiocruz); Therapeutics and vaccines for neglected tropical diseases (NTDs) - Eisai/Oswaldo Cruz Foundation (Fiocruz)Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Eisai Co Ltd; Oswaldo Cruz Foundation
- Class Parasitic vaccines
- Mechanism of Action Toll-like receptor 9 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria; Parasitic infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Malaria in Brazil
- 16 Jul 2016 No recent reports of development identified for research development in Malaria in Japan
- 16 Jul 2016 No recent reports of development identified for research development in Parasitic-infections in Brazil